Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Centene Corporation (CNC : NYSE)

• Company Description    Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations. Number of Employees: 61,100

• Price / Volume Information    Yesterday's Closing Price: $59.14 Daily Weekly Monthly 20 Day Moving Average: 7,405,926 shares Shares Outstanding: 493.80 (millions) Market Capitalization: $29,203.15 (millions) Beta: 1.06 52 Week High: $60.76 52 Week Low: $25.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 43.93% 36.90% 12 Week 37.76% 27.35% Year To Date 43.72% 29.07%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7700 FORSYTH BOULEVARD - ST LOUIS,MO 63105 USA ph: 314-725-4477 fax: 314-558-2428 investors@centene.com http://www.centene.com

• General Corporate Information    Officers Sarah M. London - Chief Executive Officer Andrew L. Asher - Executive Vice President; Chief Financial Officer Katie N. Casso - Senior Vice President; Finance; Corporate Controll Jessica L. Blume - Director Kenneth A. Burdick - Director Peer Information Centene Corporation (JUNP.) Centene Corporation (GNOW) Centene Corporation (CI) Centene Corporation (OHP) Centene Corporation (SFGH) Centene Corporation (HUM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-HMO Sector: Medical CUSIP: 15135B101 SIC: 6324 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 07/24/26 Share - Related Items Shares Outstanding: 493.80 Most Recent Split Date: 2.00 (2.00:1) Beta: 1.06 Market Capitalization: $29,203.15 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.77 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.45 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 15.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/24/26

• Fundamental Ratios P/E Current FY Estimate: 17.14 Trailing 12 Months: 23.47 PEG Ratio: 1.14 Price Ratios Price/Book: 1.36 Price/Cash Flow: 12.62 Price / Sales: 0.15 EPS Growth vs. Year Ago Period: 16.21% vs. Previous Quarter: 383.19% Sales Growth vs. Year Ago Period: 7.13% vs. Previous Quarter: 0.44% ROE 03/31/26 - 5.57 12/31/25 - 4.25 09/30/25 - 7.82 ROA 03/31/26 - 1.54 12/31/25 - 1.24 09/30/25 - 2.38 Current Ratio 03/31/26 - 1.12 12/31/25 - 1.10 09/30/25 - 1.08 Quick Ratio 03/31/26 - 1.12 12/31/25 - 1.10 09/30/25 - 1.08 Operating Margin 03/31/26 - 0.63 12/31/25 - 0.53 09/30/25 - 1.08 Net Margin 03/31/26 - -3.25 12/31/25 - -3.43 09/30/25 - -2.85 Pre-Tax Margin 03/31/26 - -3.22 12/31/25 - -3.45 09/30/25 - -2.60 Book Value 03/31/26 - 43.54 12/31/25 - 40.76 09/30/25 - 42.79 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.76 12/31/25 - 0.87 09/30/25 - 0.83 Debt-to-Capital 03/31/26 - 43.17 12/31/25 - 46.45 09/30/25 - 45.51

Powered by Zacks Investment Research ©